FdaApplication

ANDA 217277

Back to search

Identifiers

Properties

PropertyValue
applicant_nameALKEM LABORATORIES LTD
application_typeANDA
approval_date2025-01-14

Products (3)

ProductActive ingredientStrengthDosage form
CARBAMAZEPINECARBAMAZEPINE400MGTABLET, EXTENDED RELEASE;ORAL
CARBAMAZEPINECARBAMAZEPINE100MGTABLET, EXTENDED RELEASE;ORAL
CARBAMAZEPINECARBAMAZEPINE200MGTABLET, EXTENDED RELEASE;ORAL

3 products